Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"

Clinical trial NCT03219723 · COMPLETED

Trial details

NCT number: NCT03219723
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other

Start date: 2015-09-01
Primary completion: 2017-04-30
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.